ImmunityBio, Inc. (IBRX)

ImmunityBio Revenue

ImmunityBio had revenue of $6.11M in the quarter ending September 30, 2024, with 7,346.34% growth. This brings the company's revenue in the last twelve months to $7.33M, up 1,218.71% year-over-year. In the year 2023, ImmunityBio had annual revenue of $622.00K with 159.17% growth.

• Revenue (ttm): $7.33M
• Revenue Growth: +1,218.71%
• P/S Ratio: 243.47
• Revenue / Employee: $11,675
• Employees: 628
• Market Cap: 1.83B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	622.00K	382.00K	159.17%
Dec 31, 2022	240.00K	-694.00K	-74.30%
Dec 31, 2021	934.00K	329.00K	54.38%
Dec 31, 2020	605.00K	-1.60M	-72.52%
Dec 31, 2019	2.20M	-955.00K	-30.25%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.